Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Crit Care Med. 2022 Mar 25;50(7):1040–1050. doi: 10.1097/CCM.0000000000005518

TABLE 2.

Global Open Source Severity of Illness Score-1 Test Set Performance Versus Acute Physiology and Chronic Health Evaluation-IIIj and Acute Physiology and Chronic Health Evaluation-IVa

Prediction
Algorithm (Test
Cohort)
n Observed
Death
Rate, %
Average
Predicted
Death
Rate, %
Area Under the Receiver Operator
Characteristic
Curve (95% CI)
Standardized
Mortality Ratio
(95% CI)
Brier
Score
Hosmer-
Lemeshow
Test Statistic
(8 Degrees
of Freedom)
GOSSIS-1 (overall) 114,079 8.4 8.5 0.918 (0.915–0.921) 0.986 (0.966–1.005) 0.050 103.32
GOSSIS-1 (ANZICS-APD) 74,761 8.1 8.2 0.925 (0.922–0.928) 0.982 (0.957–1.007) 0.047 87.77
GOSSIS-1 (eICU-CRD)a 39,318 9 9.1 0.904 (0.9–0.909) 0.992 (0.959–1.024) 0.055 25.14b
APACHE-IIIj (ANZICS-APD) 74,761 8.1 13.6 0.904 (0.9–0.908) 0.594 (0.579–0.609) 0.059 2,918.60
APACHE-IVa (eICU-CRD)a 34,398 9.1 11.8 0.869 (0.863–0.876) 0.77 (0.743–0.797) 0.063 338.71b

ANZICS-APD = Australian and New Zealand Intensive Care Society Adult Patient Database, APACHE = Acute Physiology and Chronic Health Evaluation, eICU-CRD = eICU Collaborative Research Database, GOSSIS-1 = Global Open Source Severity of Illness Score-1.

a

The inclusion criteria for GOSSIS-1 and APACHE-IVa differ slightly due to the imputation approach used in GOSSIS-1. In particular, the GOSSIS-1 and the APACHE-IVa test sets differ by 4,920 patients (all among eICU-CRD patients). The excluded patients—those without an APACHE-IVa prediction were excluded because they had missing data related to non-Acute Physiology Score 3 (e.g., Glasgow Coma Score and chronic comorbidities) related components of the APACHE-IVa prediction equation. When compared on the same set of patients (i.e., those with an APACHE-IVa inhospital mortality prediction), the results remained relatively unchanged, with GOSSIS-1 achieving an area under the receiver operator characteristic curve (AUROC) of 0.906 (95% CI, 0.901–0.911), Brier score of 0.054, and standardized mortality ratio (SMR) of 0.997 (95% CI, 0.962–1.032). In the 4,920 patients without an APACHE-IVa score, there were no significant reductions in discriminative performance (AUROC, 0.893; 95% CI, 0.878–0.907) nor calibration (Brier score, 0.059; SMR, 0.957; 95% CI, 0.866–1.047) of GOSSIS-1.

b

Calculated on a common set of 34,398 patients who had both GOSSIS-1 and APACHE IVa scores.